Category Archives: Health

Bodycraft Clinic launches groundbreaking skin and hair rejuvenation treatment YouthX in India

India, 20 May 2024:Bodycraft Clinic, a leading name in advanced aesthetic treatments, recently announced the launch of YouthX, a groundbreaking skin and hair rejuvenation treatment. YouthX harnesses the potent capabilities of Bone Marrow cells to revolutionise skin and hair rejuvenation. Bodycraft Clinic is one of the first clinics in India to offer this innovative technology.

YouthX’s formulations trigger cell growth and repair by stimulating collagen synthesis thus fostering firmer, smoother skin while diminishing wrinkles. Moreover, YouthX accelerates tissue repair, minimising blemishes like acne scars and hyperpigmentation for a renewed complexion. For those seeking voluminous hair, YouthX offers a specialised solution targeting dormant follicles, fostering thicker, healthier growth for a fuller mane.

Commenting on the launch, Sahil Gupta, CEO of Bodycraft says, “Bodycraft Clinic is proud to introduce YouthX, a breakthrough solution at the intersection of science and nature. YouthX delivers a transformative client experience, driving superior results in skin and hair rejuvenation. Our commitment is to bring the advanced treatments that are available worldwide, right to our clients.”

YouthX is a clinically tested treatment that is proven to deliver effective results in promoting cellular health. This treatment utilizes tiny vesicles, acting like messengers between cells, that are packed with beneficial molecules. These microscopic packages, millions of times smaller than a human hair, are confirmed to contain a wealth of growth factors and proteins known to enhance cellular regeneration and reduce inflammation.

“In my practice, I always seek innovative, evidence-based approaches to improve patient outcomes. YouthX aligns with this philosophy perfectly. The core therapy utilizes a derivative of bone marrow stem cells, specifically excluding genetic material like DNA and RNA. This approach holds promise for regenerating and repairing skin tissue. Combined with natural rejuvenation techniques, YouthX offers a compelling path to achieving optimal aesthetic results and a renewed sense of well-being for my patients,” said Dr. Mikki Singh, founder and Medical Director of Bodycraft Clinic.

With YouthX, Bodycraft introduces a pioneering duo of treatments tailored to individual needs: YouthX Skin addresses hyperpigmentation, scars and marks, fine lines, and the appearance of pores, while YouthX Hair promotes natural, healthy hair growth – without surgery or hormonal side effects!

The field of aesthetics is constantly evolving, with new technologies emerging that offer minimally invasive and more personalised approaches to achieving desired results. Treatments like YouthX represent a promising area of development, and Bodycraft Clinic is proud to be at the forefront of offering this innovative technology to our clients.

Citizens Specialty Hospital Hosts India’s First CME on E-CPR in ED, Sets New Milestone in Emergency Medicine

Hyderabad, 20th May 2024: Citizens Specialty Hospital marked a significant milestone by hosting the country’s first Continuing Medical Education (CME) session on CODE E-CPR in the Emergency Department (ED) at its Hyderabad facility. The event witnessed the participation of 60 delegates and 20 faculties, comprising esteemed medical professionals and experts in the field.
CODE E-CPR, an abbreviation for Extracorporeal Cardiopulmonary Resuscitation, is a groundbreaking salvage procedure that involves the emergent initiation of extracorporeal membrane oxygenation (ECMO) on patients who have experienced cardiac arrest, particularly when conventional cardiopulmonary resuscitation (CCPR) has proven ineffective.
Dr Imron Subhan, Executive Chairman of the Society for Emergency Medicine India (SEMI) board, honored the event with his distinguished presence as the Chief Guest. Dr Subhan remarked, “This CME marks a pivotal moment in the landscape of emergency medical care in India. It is the first of its kind dedicated to E-CPR, especially within an ED setup congratulate the citizens ED team lead by Dr Sridhar Maram. Citizens Specialty Hospital’s initiative reflects a commitment to advancing medical knowledge and improving patient outcomes.”
The ceremonial lamp lighting was conducted by esteemed Dr Mir Raza Ali Khan, Dr Sridhar Maram , Dr Sudhir Koganti, Dr Gopal, along with Dr Amarendra Singh, Dr Dr Santosh Kumar Paiaulla, Dr Lakshmi Sasidhar Puvvula, Dr Bharath Kumar Pamulapati signifying the illumination of knowledge and expertise in the field of emergency medicine.
Dr Imron Subhan emphasized the significance of such initiatives, stating, “Incorporating ECPR into emergency medical protocols has the potential to revolutionize resuscitation efforts and save countless lives. It’s encouraging to witness institutions like Citizens Specialty Hospital taking proactive steps in this direction.”
Dr Sridhar Maram ( HOD ER ), Organising Chairman for this CME on CODE E CPR IN ED stated that this is the first CME in India on ECMO CPR especially in ED setting with incorporation of selection criteria of patient and protocol approach in initiation of E CPR which will help all ER Physicians to initiate and resuscitate of a cardiac arrest patient.
Dr Mir Raza Ali Khan, (Director Medical operations and quality) Citizens Specialty Hospital, expressed his enthusiasm for the event, stating, “The introduction of ECPR represents a paradigm shift in our approach to cardiac arrest management. This CME serves as a platform for sharing best practices and fostering collaboration among healthcare professionals.”
Citizens Specialty Hospital remains committed to driving innovation and excellence in healthcare, with a focus on enhancing patient care and outcomes through continuous education and collaboration within the medical community.

MERIL’s Next-Gen Myval THV Series Marks India’s Triumph in Global Heart Valve Sector

Hyderabad, 18 May 2024: Exciting news from Meril Life Sciences! The LANDMARK trial’s 30 days primary outcomes were presented on 15th May at EuroPCR 2024, Paris, France. LANDMARK was recognized by EuroPCR as one of the top three late breaking trials poised to transform revolutionise current practices in the field of Interventional Cardiology.

The LANDMARK study showed that the performance of Myval THV series in terms of safety and effectiveness was non-inferior to the contemporary THV series (24.7% vs. 27.0%, occurrence of primary composite endpoint which is composite of deaths, stroke, major bleeding, acute kidney injury, major vascular complications, moderate or severe valve regurgitation, and the need for new permanent pacemaker implantation as per the third Valve Academic Research Consortium consensus) with no difference in the itemized components of the primary composite endpoints. The other secondary endpoints including technical success at exit from procedure room, device success at 30 days and early safety at 30 days were comparable in both the groups.

Professor Serruys, Chairman & study director of the LANDMARK trial, said “Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating conventional, intermediate and extra-large diameters with increasing diameter steps of 1.5mm that match and fit precisely the multi slice CT scan-defined aortic annulus area of each individual patient, as a result, provides a superior effective orifice area on echocardiography, which may impact on durability and long-term clinical outcomes. Additionally, the Myval Octacor, with its 2 rows of octagonal cells and a minimal foreshortening of 19% during expansion, has unique features not paired by any other contemporary design.”

Myval THV series has a versatile range of sizes offering not only traditional sizes (20 mm, 23 mm, 26 mm, 29 mm) but also intermediate (21.5 mm, 24.5 mm, 27.5 mm) and extra-large sizes (30.5 mm and 32 mm). This tailored sizing matrix allows cardiologists to select the appropriate valve size, thus avoiding excessive over- or under-sizing. In the LANDMARK trial, 48.1% of the patients were implanted with the intermediate size of Myval THV series.

As per the Global Principal Investigator, Prof. Andreas Baumbach, “The Landmark trial showed that the Myval THV series performed as safe and effective as contemporary THV series. It is a valve made for everyday clinical practice and an all-comers population. The special feature of intermediate diameters allows for more accurate sizing, which has the potential to translate into improved long-term outcomes. Our patients will be followed up for 10 years and it will be interesting to see the long-term results in the three treatment arms.”

Mr. Sanjeev Bhatt, Sr. Vice President – Corporate Strategy at Meril said, ” In a successful development in structural heart interventions, the LANDMARK RCT has revealed compelling results for the novel Myval transcatheter heart valve (THV) series, confirming its non-inferiority to other contemporary THV devices. The results of LANDMARK trial are not just a win for us but for the entire medical community and, most importantly, for patients undergoing TAVI. This study not only reinforces the safety and efficacy of the Myval THV series but also highlights its adaptability to challenging anatomical structures,”.

AHF India Cares, Palladium India Partner for Nationwide HIV Testing Project

17-05-2024, India – As we celebrate World HIV Vaccination Day on May 18th every year, it’s imperative to acknowledge the stark reality: an estimated 38 million people worldwide are living with HIV/AIDS, of which 2.3 million are in India alone. As HIV vaccine remains elusive, the significance of early diagnosis and linkage to care for People Living with HIV (PLHIV) cannot be overstated. Early detection allows for timely intervention and treatment, which can significantly improve health outcomes and quality of life for PLHIV. Moreover, proper linkage to care ensures that individuals receive comprehensive medical attention. It also facilitates ongoing monitoring of the virus’s progression, management of symptoms, and prevention of opportunistic infections.

The early diagnosis and linkage to care have significantly improved the lives of millions of individuals like Ranjita Devi (name changed) whose life took an unexpected turn in February 2023. At one of the screening camps in Samastipur, Bihar, organized by Palladium as part of the Community Based HIV Testing and Linkage (CBHTL) project by AHF India Cares, she tested positive for HIV.

As part of the National HIV Counseling and Testing protocol, Ranjita underwent a confirmatory test at the nearest Integrated Counseling and Testing Centre. The results were perplexing – while kit 1 showed a negative outcome, kit 2 displayed a positive result. Seeking clarity, Ranjita was referred to a hospital in Muzaffarpur for another confirmatory test. However, even after repeated tests, the outcome remained unchanged, plunging Ranjita deeper into despair.

Recognizing the urgency of the situation, the Palladium team reached out to the ICTC Counselor at the District Hospital, initiating a chain of consultations for determining the correct diagnosis. With the intervention of Bihar SACS, an Eliza test was conducted at the blood bank in Samastipur. Finally, Ranjita underwent the confirmatory test in January 2024, which conclusively confirmed her diagnosis. Ranjita was immediately put on treatment.

The correct and early diagnosis and subsequent linkage to care were crucial in Ranjita’s journey. With the support of healthcare professionals and compassionate guidance from the ART Center doctors, she understood that HIV is not the end of the world. She gained a deeper understanding of the pervasive taboo surrounding HIV, recognizing the complex societal attitudes and misconceptions that contribute to discrimination and marginalization of those living with the virus. Today Ranjita is living a healthy life with dignity and creates awareness around her about HIV.

Mr. Amit Patjoshi, CEO, Palladium India, said, “We extend our heartfelt gratitude to AHF India Cares for this invaluable partnership.” He further added, “Recognizing the significance of last-mile support, AHF India Cares collaborated with Palladium India to bolster community-based rapid testing, counseling, and linkage services across 9 States and 22 districts of India. Palladium is working within the framework of the National AIDS and STI Control Programme (NACP) to ensure that no individual is left behind in the fight against HIV/AIDS. In 2023, the project screened a total of 2,51,000 persons with and attained a 90% linkage to Antiretroviral Therapy (ART). While this year, the program has already screened 66,187 people for HIV, of which 994 people are HIV positive with 84% linked to ART.

HIV care means embracing early diagnosis and treatment, empowering individuals to take control of their health, and fostering a community of support and compassion. Together, we can break barriers, save lives, and build a healthier, brighter future.

DMCH launches largest-ever outreach programme

Dayanand Medical College and Hospital (DMC&H) has launched the largest ever cardiovascular diseases (CVDs) outreach program, the India Hypertension Control Initiative (IHCI) in private sector in Ludhiana. The initiative named “Ek (1) ne Bees (20)” has galvanized volunteers and trained them to identify high blood pressure patients. Under the program one volunteer screens 20 people every week.

DMC&H has developed training infrastructure to train medical students, nursing staff & senior secondary students to spread awareness and has so far screened more than 1 lakh people. The DMC&H now targets 2000 volunteers in both urban and rural areas so that more and more people can be screened. The hospital has also involved corporates, schools, NGOs, and others in this outreach program.

“The commitment of industry, corporates, business houses and educational institutions including schools to improve community health is commendable, and it was evident through their active involvement during the program,” said Sunil Kant Munjal, President, DMC&H Management Society on the eve of World Hypertension Day (17th May). This is a one-of-a-kind initiative across the country where students of class XI and XII under the supervision of doctors were trained to identify CVDs and treat the patients. Buoyed with success, DMC&H is now intending to train the guards, security personnel, and support staff of different localities.

“This wide coverage has been made possible by training commoners like school students. If we have to achieve the 25 by 25, we need more people to impart knowledge and awareness,” said Dr Gurpreet S Wander, Professor of Cardiology and Principal of DMC&H. The Government of India has launched IHCI to control CVDs. An estimated 20 crore people nationwide have high blood pressure but less than 2 crore have it under control which is around 10 percent. The government intends to raise it to 25 percent by 2025.

“We are excited to launch the India Hypertension Control Initiative in Ludhiana, which underscores our commitment to combating cardiovascular diseases at the grassroots level,” said Bipin Gupta, Secretary DMC&H Management Society. Cardiovascular diseases, which include heart attacks and stroke, are the most common cause of mortality and morbidity across the world and are responsible for one-third of total deaths in India.
While the deaths due to CVDs are decreasing in rich countries, they are increasing in low and middle-income countries. Hypertension contributes to an estimated 1.6 million deaths annually in India, due to ischemic heart disease and stroke.

The India Hypertension Control Initiative is a multi-partner, five-year initiative between the Ministry of Health & Family Welfare, the Indian Council of Medical Research (ICMR), State Governments, WHO India, and the non-government organization Resolve to Save Lives.

MedRabbits Healthcare Announces Strategic Collaboration with AB Bank PLC, Dhaka

India, May 15, 2024 : MedRabbits Healthcare, a pioneering integrated healthcare service based in India, announces strategic partnership with the signing of a Memorandum of Understanding (MoU), aimed at extending exclusive benefits medical value travel and other benefits to AB Bank customers and employees. Under this agreement, AB Bank cardholders and customers will enjoy discounts of up to 50% on healthcare services provided by MedRabbits, enhancing accessibility to quality medical care.

The signing ceremony, held at AB Bank’s headquarters at Dhaka, was attended by senior officials from both organizations. Representing AB Bank PLC. was Mr. Md. Rezaul Shahriar, Executive Vice President and Head of Branches and Distribution and Mr. Md. Zakir Hossain, Vice President & Head of Cards – Retail banking division. MedRabbits was represented by its CEO Mr. Amol R Deshmukh.

Mr. Md. Rezaul Shahriar, expressed his enthusiasm about the partnership, stating, “We are thrilled to collaborate with MedRabbits to offer our valued cardholders exclusive healthcare benefits. This strategic alliance reinforces our commitment to improving customer experience and well-being.”

In response, Mr. Amol R Deshmukh, Founder and CEO, MedRabbits Healthcare, emphasized the importance of the partnership, stating, “This collaboration with AB Bank PLC. represents a significant step towards our goal of making quality healthcare services accessible to more individuals. We are excited about the opportunity to positively impact the health and well-being of AB Bank’s cardholders and employees.”

This partnership underscores the shared vision of both organizations to promote health and wellness within the community by facilitating affordable access to essential healthcare services. Additionally, MedRabbits collaborated with NRBC Bank PLC and Dhaka Bank Limited in October 2023, to host employee health camps.

Aster Medcity Introduces Latest Hip Replacement Technology for the First Time in Kerala

Kochi, 15th May- 2024: Aster Medcity introduced the first Direct Anterior approach in Total Hip Replacement (THR) in Kerala, introducing an innovative technique that originated recently in the USA. This cutting-edge technology, clinically proven to surpass existing methods, marks a significant advancement in orthopedic surgery. The Direct Anterior approach, performed for the first time in Kerala at Aster Medcity, offers superior benefits over traditional hip replacement procedures. Unlike conventional techniques that involve cutting or separating muscles from the bone, this innovative approach utilizes a new path to access the hip joint with better accuracy, resulting in enhanced patient outcomes.

The milestone procedure, conducted on a 55-year-old individual had been suffering from hip pain for the past three years. Despite previous recommendations for hip replacement from multiple hospitals, the patient was apprehensive until the pain became unbearable, prompting a visit to Aster Medcity.

With the Direct Anterior approach, patients experience reduced pain, minimal blood loss, and accelerated post-operative rehabilitation. The technique enables patients to lie comfortably during surgery and facilitates immediate post-operative ambulation, leading to faster recovery compared to conventional methods.

“This is going to be a mile stone and game changer in the total hip replacement surgeries with so much of advantages to the patient during and after the surgery,” said Dr. Vijaya Mohan S, Senior Consultant – Orthopaedic Surgery. Aster Medcity-Kochi.

Farhaan Yasin, The Vice president, Aster India commented that this is an excellent example of Aster’s commitment to people of Kerala to bring the latest technology and benefits in treatment developments to Kerala without any delay whenever it happens anywhere in the world.

The Indian Chest Society unveils special booklet on Cough Management

India, May 15th, 2024: The Indian Chest Society (ICS) today unveiled a special booklet titled ‘Guidelines For Cough Management in India’, focusing on the comprehensive management of cough in India. This initiative comes at a crucial time when respiratory health is of paramount concern globally. The special booklet is part of ICS’ medical initiative supported by Dr. Reddy’s Laboratories Limited (Dr. Reddy’s), a global pharmaceutical company headquartered in Hyderabad, India as a scientific partner.

Through this booklet, ICS aims to illuminate the prevalence of cough, explore its diverse causes, and provide insights into its diagnosis and management. With dedicated sections on both dry and wet cough management, considerations regarding red flags, appropriate times for specialist referral, the relevance of fixed-dose combinations (FDCs), and a critical examination of banned FDCs in India, the booklet offers evidence-based strategies for clinicians to tailor their treatment approaches accordingly.

To enhance informed decision-making in clinical practice, the booklet also includes a section on fixed-dose combinations which are better alternatives to codeine-based combinations for managing dry cough, and sheds light on appropriate Beta-2 receptor agonists for wet cough management.

The distinguished panel of eight pulmonologists, comprising Dr. R Vijai Kumar, Vice President of ICS, Dr. Deepak Talwar, Honorary Secretary of ICS, Dr. PradyutWaghray, Dr. Maulik Sanghvi, Dr. S Z Jafrey, Dr. Mahavir Modi, Dr. Meghana Subhash, and Dr. Visweswaran, has been instrumental in shaping the content of this booklet

Speaking about the initiative, Dr. R Vijai Kumar from ICS said, “We believe that this initiative will serve as a valuable resource for healthcare professionals across the country, contributing to enhanced patient care and improved outcomes in cough management. We would also like to thank Dr. Reddy’s for providing scientific support.”

DocTube Launches Mother’s Day Campaign Focusing on Mental Health of Mothers

Mumbai, 14.05.2024 – DocTube, the leading platform for public awareness health content, is thrilled to announce its upcoming Mother’s Day campaign, dedicated to raising awareness about the mental health of mothers. This campaign features 10 esteemed doctors who create insightful content, culminating in the release of 50+ engaging videos on DocTube.

The mental well-being of mothers is a crucial but often overlooked aspect of healthcare. Through this campaign, DocTube sheds light on various mental health challenges that mothers face and provides valuable insights, tips, and resources to support their mental wellness journey.

The campaign features a diverse range of topics, including maternal stress management, postpartum depression, work-life balance for mothers, coping mechanisms for parenting challenges, and self-care practices for mothers.

The campaign kicked off on 12.05.2024, with new videos being released daily on DocTube’s platform and will continue until 14.05.2024. In this campaign, renowned gynecologists and psychiatrists such as Dr. Harish Shetty, Dr. Kersi Chavda, Dr. Shubhangi Raghunath Parkar, Dr. Ardhanaari Manickavasagam, Dr. Debanjan Banerjee, Dr. Sunila Khandelwal, along with many other prominent names in the field, are sharing their valuable insights on maternal mental health. The campaign addresses critical topics including post-partum depression and its impact on mother and child, as well as menopause and its effects on mental health. These discussions are presented in various vernacular languages such as Tamil, English, Hindi, and Bengali, catering to diverse audiences across the country.

HCG Expands with Two New Comprehensive Cancer Care Centers in Bengaluru

Bengaluru, May 14, 2024: Healthcare Global Enterprises Limited (HCG) is expanding its footprint in Bengaluru with the launch of its two new state of the art, comprehensive cancer care centres in Whitefield and North Bengaluru. With this strategic expansion, India’s largest cancer care network plans to extend specialized and advanced modes of cancer treatment to these two highly populated neighborhoods in the city, making them the third and fourth in its hospital network in Bengaluru. The two strategically located centres will commence operations in early 2025.

Both facilities will provide the entire spectrum of cancer care, from high precision diagnosis to personalized treatment plans, all under one roof. The Whitefield and the North Bengaluru facility with integrated and holistic cancer care will accommodate a total of 125 beds. The two additions to the HCG chain of cancer care hospitals in the city share locational advantage similar to the HCG’s flagship Centre of Excellence at KR Road and Double Road with a total of 300 beds. Along with these four modern centres, HCG has three daycare centers in the residential neighborhoods of Kalyan Nagar, Malleshwaram and Banashankari. HCG plans to add two new day care centres to the city network to reduce travel time and make cancer care easily accessible to patients who need repeated treatments like chemotherapy. With the introduction of the MR LINAC radiation system in its North Bangalore facility, HCG is poised to revolutionize radiation therapy in the state. This state-of-the-art technology integrates magnetic resonance imaging (MRI) with linear accelerator (LINAC) to improve clinical outcomes, decrease side effects and reduce treatment period.

Dr. B S Ajaikumar, Executive Chairman, Healthcare Global Enterprises Limited said, “As Bengaluru evolves into a metropolis, HCG remains outcome-focused on its mission to bring world-class cancer care closer to a wider population. Our new advanced centres at Whitefield and North Bengaluru are pivotal to our aim of extending our network to the local community sustainably, ensuring high-quality cancer care is accessible to all. With Bengaluru being HCG’s home ground, this expansion not only reflects our deep-rooted connection to the city but also our commitment to enhancing the healthcare landscape for the benefit of the local community”.

Mr Raj Gore, CEO, HealthCare Global Enterprises Ltd said, ” In a sector marked by demand-supply gap and fragmentation, there exists significant potential for growth and consolidation. We are focused on expanding our reach and taking HCG’s comprehensive & quality cancer care services closer to patients in and around Bengaluru. As a leading healthcare provider dedicated to excellence, we remain firm in our commitment to investing in new infrastructure, advanced treatments, and cutting-edge technology”.

HCG has further reiterated its position as a leading cancer care provider in the region. HCG’s present network encompasses 21 comprehensive cancer centres with 24 hospitals across India and Africa, and seven-day care centres.